J&J Acquires Rights to IBD Experimental Drug from Vedanta
IBD News, News
Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has signed a license agreement with Vedanta Biosciences to acquire the rights for an investigational therapeutic alternative for ... Read more